Topic Antibodies

Products

ELISA kits for the measurment of SDF-1/CXCL12

SDF-1α (CXCL12) is a CXC chemokine. The small basic protein (ca. 8 kDa) has no glycosylation site in its sequence. The homology properties of SDF-1α are unique among the chemokines more

Catalogues

Fat Cells, Immune Cells and Metabolic Syndrome

The Importance of the research into Metabolic Syndrome and related diseases is fascinating. Which methods and tools do experts use? more

Santa Cruz Biotechnology now offers over 56,100 well characterized primary antibodies

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market, offering over 56,100 well characterized more

Premium Companies in this Key Topic:

Companies antibodies

INTEGRA Biosciences AG, Switzerland

INTEGRA Biosciences is a leading manufacturer of high quality, reliable and convenient to use labtools and equipment for Microbiology and Cell Cultivation applications. We are committed to creating innovative solutions which fulfil the needs of our customers in research, diagnostics and quality con more

Agrisera AB, Sweden

Agrisera provides high quality antibodies for research on various aspects of plant & algal cell biology including miRNA, stress, photosynthesis and others including marker antibodies for plant cellular compartments. Our antibody collection contains also unique reagents animal cell biology research. more

PeproTech GmbH, Germany

PeproTech was established in 1988 by a group of scientists who focussed their efforts on the development and production of recombinant cytokines for life-science research. Today, PeproTech is a world leader in supplying high quality cytokine products including more than 350 E. coli, insect, and mamm more

Products antibodies

ELISA kits for the measurment of SDF-1/CXCL12

SDF-1α (CXCL12) is a CXC chemokine. The small basic protein (ca. 8 kDa) has no glycosylation site in its sequence. The homology properties of SDF-1α are unique among the chemokines more

Catalogues antibodies

Santa Cruz Biotechnology now offers over 56,100 well characterized primary antibodies

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market, offering over 56,100 well characterized more

News antibodies

• Agenix: Patent In Japan for Diagnostic Technology

  Agenix Limited  announced that Japan's Patent Office had granted a key patent covering the manufacturing process of its ThromboView® imaging agent for the detection of blood clots in humans. Agenix Chairman and Chief Executive Officer, Nicholas Weston said, "The granting of patent protection in Japa more

• GE Healthcare Life Sciences completes acquisition of Xcellerex, Inc.

  GE Healthcare announced that it has completed the acquisition of Xcellerex, Inc., a supplier of manufacturing technologies for the fast-growing biopharmaceutical industry. The acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of biopharmaceuticals such as more

• 4-Antibody AG and Evotec AG Form Strategic Collaboration

  4-Antibody AG and Evotec AG announced the signing of a strategic collaboration agreement under which Evotec will offer a fully integrated antibody discovery and development service. Evotec’s novel and unique high throughput and high content screening approach coupled with 4-Antibody’s high throughpu more

White papers antibodies

• Promotion of Aggregation as a Means of Assessing the Stability of Antibody Molecules
  

  The efficiency of antibody molecules is dependent on their stability. We introduce an assay setup where stability of antibodies is measured. Shaking stress is initiated by the FLUOstar Omega microplate reader and aggregation propensity of antibody candidates is measured in 96-well format more

• Clinical Biomarkers: Novel Tools for Pharmacodynamic Applications
  

  Biomarkers are currently changing the way we diagnose and treat diseases. Today pharmacodynamic biomarkers are widely used in the industry elaborating optimal dosing of new drugs and predictive biomarkers have an enormous potential for companion diagnostics more

• Characterizing Biotherapeutics with HPLC
  

  As demonstrated here, there are a broad range of HPLC applications used in development, production, validation and release of protein therapeutics for human use. Some of the applications mentioned above are mandatory when submitting a new biopharmaceutical to approval at the regulatory agencies. The introduction of the first so-called biosimilars in Europe further increased the demand for highly efficient analysis methods. The continuous development of new stationary phases for the common modes of biochromatography, such as size exclusion, ion exchange and hydrophilic interaction chromatography support biochemists in increasing lab productivity and establishing high-throughput HPLC analysis not only for small molecules but also for large biopolymers more

Publications antibodies

• Engineering of an anti‐epidermal growth factor receptor antibody to single chain format and labeling by sortase A‐mediated protein ligation

  Abstract Sortase‐mediated protein ligation is a biological covalent conjugation system developed from the enzymatic cell wall display mechanism found in Staphylococcus aureus. This three‐component system requires: (i) purified Sortase A (SrtA) enzyme; (ii) a substrate containing the LPXTG peptide more

• Case Report: Risk of virus infection after accidental blood inoculation from a multi‐infected AIDS patient

  Abstract Infections caused by blood‐borne viruses such as hepatitis B and C and the human immunodeficiency virus (HIV) are associated commonly with needlestick injuries, especially in a hospital setting. A prospective investigation was conducted on a medical doctor who suffered an accidental need more

• Structural glycobiology of the major allergen of Artemisia vulgaris pollen, Art v 1: O-glycosylation influence on the protein dynamics and allergenicity

  Art v 1 is the major allergen of mugwort (Artemisia vulgaris) pollen. It is formed by an N-terminal globular defensin-like part and a C-terminal proline-rich domain. As the structure and the dynamics of Art v 1 have been mostly described for its recombinant, non-glycosylated form, which does not oc more

Market studies antibodies

• Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes

  GBI Research’s report, “Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes”, provides in-depth analysis of biologics recalls issued or reported with the US Food and Drug Administration (FDA) and its constituent agencies. T more

• Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017

  Leading business intelligence provider GBI Research has released its latest research report, “Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017”, which provides insight about immunomodulators sales forecasts until 2017.I Imm more

• IRI SEPARATION TECHNOLOGIES INC. - Strategic SWOT Analysis Review

  IRI Separation Technologies Inc is a biotechnology company specialized in the extraction, development and commercialization antibodies for the human nutraceutical market. The antibodies are extracted from egg yolks and bovine whey by using a proprietary process. The company is headquartered in West more

Websites antibodies